FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2

DSpace Repository

FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2

Author: Renz, Alina; Widerspick, Lina; Dräger, Andreas
Tübinger Autor(en):
Renz, Alina
Widerspick, Lina
Dräger, Andreas
Published in: Bioinformatics (2020), Bd. 36, Supplement_2, S. i813–i821
Verlagsangabe: Oxford : Oxford University Press
Language: English
Full text: https://doi.org/10.1093/bioinformatics/btaa813
DDC Classifikation: 004 - Data processing and computer science
500 - Natural sciences and mathematics
570 - Life sciences; biology
610 - Medicine and health
Keywords: SARS-CoV-2 , COVID-19 , Wirkstoff , Systembiologie , Krankheit , Modellierung , Modell
Dokumentart: Article
Note: Zunächst als Preprint auf Zenodo erschienen: https://doi.org/10.5281/zenodo.3752641
Show full item record

This item appears in the following Collection(s)